Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

PROSCA/BLADDR 2020 | Future of imaging and theranostics in prostate cancer

Jeremie Calais, MD, David Geffen School of Medicine at UCLA, Los Angeles, CA, discusses the future of radioactive imaging and theranostics in the diagnosis and treatment of prostate cancer and highlights the possibility of novel targets for imaging and treatment in addition to PSMA. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).